EQ - Company ID 0001746466
The table below shows Equillium, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | $41.09M | $36.08M | $15.76M | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | $37.04M | $37.55M | $26.38M | $19.38M |
| SG&A | $10.79M |
Equillium, Inc. reported annual revenue of $41.09M for fiscal year 2024. That is up 13.9% from $36.08M in fiscal 2023. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $11.94M |
| $13.57M |
| $17.24M |
| $11.41M |
| $10.16M |
| Operating income | -$23.63M | -$8.27M | -$14.52M | -$62.08M | -$37.79M | -$29.55M |
| Income tax | $0.00 | $361.00K | $580.00K | $0.00 | $0.00 | $0.00 |
| Net income | -$22.40M | -$8.07M | -$13.34M | -$62.43M | -$39.05M | -$29.81M |
| EPS (diluted) | -$0.39 | -$0.23 | -$0.38 | -$1.85 | -$1.36 | - |